Manulife (Manufacturers Life Insurance)’s Repros Therapeutics Inc. RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,311
Closed -$1K 4536
2017
Q2
$1K Sell
1,311
-10
-0.8% -$7 ﹤0.01% 4346
2017
Q1
$2K Hold
1,321
﹤0.01% 3997
2016
Q4
$2K Hold
1,321
﹤0.01% 4156
2016
Q3
$3K Hold
1,321
﹤0.01% 4044
2016
Q2
$2K Hold
1,321
﹤0.01% 4068
2016
Q1
$1K Hold
1,321
﹤0.01% 4099
2015
Q4
$2 Hold
1,321
﹤0.01% 3856
2015
Q3
$10 Hold
1,321
﹤0.01% 3573
2015
Q2
$9 Sell
1,321
-14,890
-92% -$116K ﹤0.01% 3590
2015
Q1
$139 Buy
16,211
+68
+0.4% +$608 ﹤0.01% 3005
2014
Q4
$161 Buy
16,143
+781
+5% +$6.66K ﹤0.01% 2802
2014
Q3
$152 Sell
15,362
-48
-0.3% -$711 ﹤0.01% 2829
2014
Q2
$266K Sell
15,410
-2,317
-13% -$37.8K ﹤0.01% 2505
2014
Q1
$315 Sell
17,727
-4
-0% -$77 ﹤0.01% 2404
2013
Q4
$325 Buy
17,731
+3,717
+27% +$70.2K ﹤0.01% 2361
2013
Q3
$375 Buy
14,014
+214
+2% +$4.59K ﹤0.01% 2180
2013
Q2
$255K Buy
+13,800
New +$244K ﹤0.01% 2376

Other funds holding RPRX

Manulife (Manufacturers Life Insurance)'s RPRX Position: Q3 2017 in Review

Manulife (Manufacturers Life Insurance) sold out of Repros Therapeutics Inc. (RPRX) in Q3 2017, closing a stake of 1,311 shares — an estimated $1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in RPRX in Q2 2013 and held it in 17 quarters. The position peaked at $266K in Q2 2014. 28 funds tracked by Wall St. Rank hold RPRX as of Q3 2017.

  • Manulife (Manufacturers Life Insurance) reported no remaining Repros Therapeutics Inc. position as of Q3 2017 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,311 Repros Therapeutics Inc. shares in Q3 2017, an estimated $1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 17 quarters.
  • Manulife (Manufacturers Life Insurance)'s Repros Therapeutics Inc. position peaked at $266K in Q2 2014.
  • 28 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q3 2017.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.